Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Uchida Wakanyaku is a specialized Japanese pharmaceutical company focused on the production and sale of traditional Kampo (Japanese-Chinese) medicines and crude drugs. Founded in 1947 and headquartered in Tokyo, the company provides high-quality herbal materials, extract granules, and health supplements to medical institutions and pharmacies. They operate their own manufacturing facilities, including a GMP-compliant factory in Chiba, ensuring rigorous quality control and standardization of natural ingredients. The company's product portfolio includes a vast range of crude drugs sourced globally, processed using traditional techniques to maintain efficacy. Uchida Wakanyaku also develops and markets health foods and functional supplements based on traditional medicinal principles. By bridging ancient herbal wisdom with modern manufacturing standards, the company remains a key player in Japan's traditional medicine sector.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Uchida Wakanyaku.